ArticleTargeted oncology2018

Impact of Delayed Addition of Anti-EGFR Monoclonal Antibodies on the Outcome of First-Line Therapy in Metastatic Colorectal Cancer Patients: a Retrospective Registry-Based Analysis.

Ondrej Fiala et al.PubMed ↗Publisher ↗

No numbers read from the abstract.